Kiren Purushotorman

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice.

Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice.

Journal: The Journal of clinical investigation
Published: January 15, 2026

Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice.

Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice.

Journal: The Journal of clinical investigation
Published: May 19, 2025

Characterization of group I introns in generating circular RNAs as vaccines.

Characterization of group I introns in generating circular RNAs as vaccines.

Journal: Nucleic acids research
Published: December 19, 2024

Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals.

Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals.

Journal: The Journal of infection
Published: March 28, 2024

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines.

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines.

Journal: NPJ vaccines
Published: October 12, 2023

Analyzing COVID-19 Vaccine Responses in Transplant Recipients.

Analyzing COVID-19 Vaccine Responses in Transplant Recipients.

Journal: ImmunoHorizons
Published: September 29, 2023

Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.

Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.

Journal: NPJ vaccines
Published: September 25, 2023

Relative deficiency in interferon-γ-secreting CD4+ T cells is strongly associated with poorer COVID-19 vaccination responses in older adults.

Relative deficiency in interferon-γ-secreting CD4+ T cells is strongly associated with poorer COVID-19 vaccination responses in older adults.

Journal: Aging cell
Published: August 02, 2023

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.

Journal: Scientific reports
Published: May 21, 2023

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.

Journal: NPJ vaccines
Published: February 02, 2023

Defining neutralization and allostery by antibodies against COVID-19 variants.

Defining neutralization and allostery by antibodies against COVID-19 variants.

Journal: Nature communications
Published: January 19, 2023

Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies.

Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies.

Journal: Pathogens (Basel, Switzerland)
Published: October 25, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026